FDA Inspection 1343876 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 3017899821

The FDA completed an inspection of Octapharma Plasma Inc on Oct 22, 2026 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 22, 2026
Fiscal Year
2027
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Memphis, TN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.